UK-based real-time lymphoproliferative disorder diagnostic service to improve the management of patients in Ghana

por Parkins, Elizabeth, Owen, Roger G., Bedu-Addo, George, Sem, Ohene Opare, Ekem, Ivy, Adomakoh, Yvonne, Bates, Imelda
Publicado 2009

Quality of life during and following sequential treatment of previously untreated patients with multiple myeloma: findings of the Medical Research Council Myeloma IX randomised stu...

por Royle, Kara‐Louise, Gregory, Walter M., Cairns, David A., Bell, Sue E., Cook, Gordon, Owen, Roger G., Drayson, Mark T., Davies, Faith E., Jackson, Graham H., Morgan, Gareth J., Child, J. Anthony
Publicado 2018

Monoclonal B-cell lymphocytosis in a hospital-based UK population and a rural Ugandan population: a cross-sectional study

por Rawstron, Andy C, Ssemaganda, Aloysius, de Tute, Ruth, Doughty, Chi, Newton, Darren, Vardi, Anna, Evans, Paul A S, Stamatopoulos, Kostas, Owen, Roger G, Lightfoot, Tracy, Wakeham, Katie, Karabarinde, Alex, Asiki, Gershim, Newton, Robert
Publicado 2017

Serum free light chain levels and renal function at diagnosis in patients with multiple myeloma

por Yadav, Punit, Cockwell, Paul, Cook, Mark, Pinney, Jennifer, Giles, Hannah, Aung, Yu Sandar, Cairns, David, Owen, Roger G., Davies, Faith E., Jackson, Graham H., Child, J. Anthony, Morgan, Gareth J., Drayson, Mark T.
Publicado 2018

Autologous stem cell transplantation is safe and effective for fit, older myeloma patients: exploratory results from the Myeloma XI trial

por Pawlyn, Charlotte, Cairns, David A., Menzies, Tom, Jones, John R., Jenner, Matthew W., Cook, Gordon, Boyd, Kevin D., Drayson, Mark T., Kaiser, Martin F., Owen, Roger G., Gregory, Walter, Morgan, Gareth J., Jackson, Graham H., Davies, Faith E.
Publicado 2020

Maintenance lenalidomide in newly diagnosed transplant eligible and non-eligible myeloma patients; profiling second primary malignancies in 4358 patients treated in the Myeloma XI...

por Jones, John R., Cairns, David A., Menzies, Tom, Pawlyn, Charlotte, Davies, Faith E., Sigsworth, Rachel, Brioli, Annamaria, Jenner, Matthew W., Kaiser, Martin F., Olivier, Catherine, Reed, Molly, Drayson, Mark T., Owen, Roger G., Boyd, Kevin D., Cook, Gordon, Morgan, Gareth J., Jackson, Graham H.
Publicado 2023

Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients

por Shah, Vallari, Sherborne, Amy L., Johnson, David C., Ellis, Sidra, Price, Amy, Chowdhury, Farzana, Kendall, Jack, Jenner, Matthew W., Drayson, Mark T., Owen, Roger G., Gregory, Walter M., Morgan, Gareth J., Davies, Faith E., Cook, Gordon, Cairns, David A., Houlston, Richard S., Jackson, Graham, Kaiser, Martin F.
Publicado 2020

Response to COVID-19 Vaccines in Patients Receiving Intensified Post-ASCT Therapy with Daratumumab, Lenalidomide, Bortezomib (Dara-VR) Due to Ultra-High Risk (UHiR) Newly Diagnosed...

por Jenner, Matthew W, Hall, Andrew, Faustini, Sian E, Pitchford, Alexandra, de Tute, Ruth M., Roberts, Sadie, Ingleson, Emma, Bowles, Kristian M, Garg, Mamta, Lokare, Anand, Messiou, Christina, Jackson, Graham, Pratt, Guy, Cook, Gordon, Owen, Roger G, Brown, Sarah R, Drayson, Mark T, Kaiser, Martin F.
Publicado 2021

First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial

por Morgan, Gareth J, Davies, Faith E, Gregory, Walter M, Cocks, Kim, Bell, Sue E, Szubert, Alex J, Navarro-Coy, Nuria, Drayson, Mark T, Owen, Roger G, Feyler, Sylvia, Ashcroft, A John, Ross, Fiona, Byrne, Jennifer, Roddie, Huw, Rudin, Claudius, Cook, Gordon, Jackson, Graham H, Child, J Anthony
Publicado 2010

Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 Pandemic

por Talaulikar, Dipti, Advani, Ranjana H., Branagan, Andrew R., Buske, Christian, Dimopoulos, Meletios A., D'Sa, Shirley, Kersten, Maria J., Leblond, Veronique, Minnema, Monique C., Owen, Roger G., Palomba, Maria Lia, Tedeschi, Alessandra, Trotman, Judith, Varettoni, Marzia, Vos, Josephine M., Treon, Steven P., Kastritis, Efstathios, Castillo, Jorge J.
Publicado 2020

Carfilzomib or bortezomib in combination with cyclophosphamide and dexamethasone followed by carfilzomib maintenance for patients with multiple myeloma after one prior therapy: res...

por Yong, Kwee L., Hinsley, Samantha, Auner, Holger W., Bygrave, Ceri, Kaiser, Martin F., Ramasamy, Karthik, de Tute, Ruth M., Sherratt, Debbie, Flanagan, Louise, Garg, Mamta, Hawkins, Stephen, Williams, Catherine, Cavenagh, Jamie, Rabin, Neil K., Croft, James, Morgan, Gareth, Davies, Faith, Owen, Roger G., Brown, Sarah R.
Publicado 2021

Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised cont...

por Morgan, Gareth J, Child, J Anthony, Gregory, Walter M, Szubert, Alex J, Cocks, Kim, Bell, Sue E, Navarro-Coy, Nuria, Drayson, Mark T, Owen, Roger G, Feyler, Sylvia, Ashcroft, A John, Ross, Fiona M, Byrne, Jennifer, Roddie, Huw, Rudin, Claudius, Cook, Gordon, Jackson, Graham H, Wu, Ping, Davies, Faith E
Publicado 2011

Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial

por Jackson, Graham H, Davies, Faith E, Pawlyn, Charlotte, Cairns, David A, Striha, Alina, Collett, Corinne, Hockaday, Anna, Jones, John R, Kishore, Bhuvan, Garg, Mamta, Williams, Cathy D, Karunanithi, Kamaraj, Lindsay, Jindriska, Jenner, Matthew W, Cook, Gordon, Russell, Nigel H, Kaiser, Martin F, Drayson, Mark T, Owen, Roger G, Gregory, Walter M, Morgan, Gareth J
Publicado 2019

Copy number evolution and its relationship with patient outcome—an analysis of 178 matched presentation-relapse tumor pairs from the Myeloma XI trial

por Croft, James, Ellis, Sidra, Sherborne, Amy L., Sharp, Kim, Price, Amy, Jenner, Matthew W., Drayson, Mark T., Owen, Roger G., Chown, Sally, Lindsay, Jindriska, Karunanithi, Kamaraj, Hunter, Hannah, Gregory, Walter M., Davies, Faith E., Morgan, Gareth J., Cook, Gordon, Atanesyan, Lilit, Savola, Suvi, Cairns, David A., Jackson, Graham, Houlston, Richard S., Kaiser, Martin F.
Publicado 2020

Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly di...

por Jones, John R., Weinhold, Niels, Ashby, Cody, Walker, Brian A., Wardell, Chris, Pawlyn, Charlotte, Rasche, Leo, Melchor, Lorenzo, Cairns, David A., Gregory, Walter M., Johnson, David, Begum, Dil B., Ellis, Sidra, Sherborne, Amy L., Cook, Gordon, Kaiser, Martin F., Drayson, Mark T., Owen, Roger G., Jackson, Graham H., Davies, Faith E., Greaves, Mel, Morgan, Gareth J.
Publicado 2019

APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma

por Walker, Brian A, Wardell, Christopher P, Murison, Alex, Boyle, Eileen M, Begum, Dil B, Dahir, Nasrin M, Proszek, Paula Z, Melchor, Lorenzo, Pawlyn, Charlotte, Kaiser, Martin F, Johnson, David C, Qiang, Ya-Wei, Jones, John R, Cairns, David A, Gregory, Walter M, Owen, Roger G, Cook, Gordon, Drayson, Mark T, Jackson, Graham H, Davies, Faith E, Morgan, Gareth J
Publicado 2015

Response-adapted intensification with cyclophosphamide, bortezomib, and dexamethasone versus no intensification in patients with newly diagnosed multiple myeloma (Myeloma XI): a mu...

por Jackson, Graham H, Davies, Faith E, Pawlyn, Charlotte, Cairns, David A, Striha, Alina, Collett, Corinne, Waterhouse, Anna, Jones, John R, Kishore, Bhuvan, Garg, Mamta, Williams, Cathy D, Karunanithi, Kamaraj, Lindsay, Jindriska, Wilson, Jamie N, Jenner, Matthew W, Cook, Gordon, Kaiser, Martin F, Drayson, Mark T, Owen, Roger G, Russell, Nigel H, Gregory, Walter M, Morgan, Gareth J
Publicado 2019

Lenalidomide before and after autologous stem cell transplantation for transplant-eligible patients of all ages in the randomized, phase III, Myeloma XI trial

por Jackson, Graham H., Davies, Faith E., Pawlyn, Charlotte, Cairns, David A., Striha, Alina, Collett, Corinne, Waterhouse, Anna, Jones, John R., Kishore, Bhuvan, Garg, Mamta, Williams, Cathy D., Karunanithi, Kamaraj, Lindsay, Jindriska, Allotey, David, Shafeek, Salim, Jenner, Matthew W., Cook, Gordon, Russell, Nigel H., Kaiser, Martin F., Drayson, Mark T., Owen, Roger G., Gregory, Walter M., Morgan, Gareth J.
Publicado 2021

Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim...

por Jackson, Graham H., Pawlyn, Charlotte, Cairns, David A., de Tute, Ruth M., Hockaday, Anna, Collett, Corinne, Jones, John R., Kishore, Bhuvan, Garg, Mamta, Williams, Cathy D., Karunanithi, Kamaraj, Lindsay, Jindriska, Rocci, Alberto, Snowden, John A., Jenner, Matthew W., Cook, Gordon, Russell, Nigel H., Drayson, Mark T., Gregory, Walter M., Kaiser, Martin F., Owen, Roger G., Davies, Faith E., Morgan, Gareth J.
Publicado 2021